Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies

Amgen Inc. (NASDAQ:AMGN) is 1 of the best undervalued wide moat stocks.

A dose vessel of the medicine is successful the aesculapian tech's hand

On January 13, 2026, an announcement came regarding the Ro and Amgen Inc. (NASDAQ:AMGN) collaboration. Ro, a U.S. telehealth firm, alongside Amgen, aims to analyse barriers patients look successful accessing obesity treatments, including GLP-1 drugs specified arsenic Novo Nordisk’s Ozempic and Eli Lilly’s Zepbound.

Leveraging information from Ro’s direct-to-consumer platform, some companies purpose to measure security sum and anterior authorization requirements, place caps, and amended diligent access. The companies noted that GLP-1 therapies tin beryllium life-changing, with the wide interaction depending connected however entree is scaled. Meanwhile, Amgen Inc. (NASDAQ:AMGN) aims to capitalize connected the observational research, expecting the probe to assistance with therapy improvement and bring innovations successful attraction delivery. However, the fiscal presumption were not disclosed.

A week earlier, Amgen Inc. (NASDAQ:AMGN) acquired Dark Blue Therapeutics for up to $840 million. Dark Blue is simply a UK-based biotech institution that is advancing first-in-class tiny molecule macromolecule degraders targeting MLLT1/3 proteins successful acute myeloid leukemia (AML). Showing anti-cancer enactment and differentiation from existing therapies, the preclinical information enactment imaginable single-agent and operation attraction strategies. As it prepares to integrate Dark Blue into its probe organization, the institution aims to bolster aboriginal oncology find and reenforce its committedness to caller therapeutic mechanisms.

Amgen Inc. (NASDAQ:AMGN), a biotechnology company, develops, manufactures, and markets quality therapeutics. The institution was founded successful 1980 and is headquartered successful Thousand Oaks, CA.

While we admit the imaginable of AMGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 7 Best Rising Tech Stocks to Buy Now and 12 Best Multibagger Stocks to Buy Heading into 2026.

Disclosure: None.